Society of Thoracic Surgeons - Surgeon
NOVEMBER 16, 2023
Webinar Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC dkaczmarek Thu, 11/16/2023 - 16:01 December 14, 2023 Part 2 of a 2-part webinar series, supported by AstraZeneca This webinar will address preoperative biomarker testing and issues around neoadjuvant immunotherapy for NSCLC.
Society of Thoracic Surgeons - Surgeon
NOVEMBER 3, 2023
Plan to attend Part 2 on Thursday, December 14, titled " Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC." While both trials showed similar results, there are important differences in design, demographics, and patients’ outcomes. Moderators Robert E. Merritt, MD The Ohio State University Columbus, OH Sandra L.
Society of Thoracic Surgeons - Allied Health
SEPTEMBER 23, 2022
Webinar The Changing Face of Pretreatment Nodal Staging for Patients with Lung Cancer kchalko Fri, 09/23/2022 - 12:27 October 6, 2022 Procedures to evaluate lymph nodes before lung cancer therapy, including endobronchial guided nodal aspiration and mediastinoscopy, can help diagnose and stage the patient effectively. Moderators Janet P.
DAIC
JUNE 4, 2024
I am excited about the potential of the FAI-Score biomarker, which has promising prognostic value beyond existing CT-based methods such as plaque, calcium scoring, and CAD-RADS based interpretation." Details of the study, included in a written statement issued by Caristo Diagnostics, follow. fold higher risk for cardiac mortality and 5.5-fold
Dr. Smith's ECG Blog
JUNE 18, 2013
These patients have worse outcomes: higher mortality, more CHF, higher biomarkers, and worse ejection fractions than the NonSTEMI patients with open arteries. This is but one of many examples presented in the Webinar by Drs. Smith and Meyers in the December 5, 2023 Webinar post). This is because of subtle ECG findings.
Expert insights. Personalized for you.
52 
Let's personalize your content